Registration is still open for the Annual NAAF Conference
Whether you are newly diagnosed, have lived with alopecia areata for some time, are seeking support, or want to learn more to help a loved one, this conference is for you! Register soon and book your hotel stay at the Hilton Chicago to receive the NAAF group rate.
Join us on Saturday, September 27, 2025, at our two Flagship Sites in San Francisco & Philadelphia, 20+ Volunteer-Led Community Walk Sites, or Walk Where You Are as a team or individual.
Designed to empower individuals and families to navigate their treatment journey, this toolkit includes current information, practical strategies, and helpful resources about treatments, commercial insurance, and more.
Keira's family found hope, resources, and community with NAAF.
Your gift will help continue providing support to families when they need it most, as well as fund research to advance more treatments for alopecia areata.
Alopecia areata is a common autoimmune disease, causing sudden hair loss on the scalp, face, and sometimes other areas of the body. There are different levels of alopecia areata severity. The three main types of alopecia areata are patchy, alopecia totalis (total hair loss on the scalp), and alopecia universalis (total hair loss on the body).
Today, the U.S. Food and Drug Administration (FDA) approved LEQSELVI™ (deuruxolitinib) for alopecia areata, marking the third FDA-approved treatment for…